{
  "trial_id": "NCT00216060",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically or cytologically confirmed adenocarcinoma of the prostate",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "metastatic bone disease (by CT, MRI or bone scan) with plans to start or be < 30 days from beginning androgen deprivation therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients may receive palliative radiation therapy at the investigators discretion during the first 4 weeks of beginning protocol therapy.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "No neuroendocrine, small cell or transitional cell cancer of the prostate",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No abnormal bone metabolism (i.e., Paget's disease, untreated hyperthyroidism, untreated hyperprolactinemia, untreated Cushing's disease).",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "No use of calcitonin within 14 days before being registered for protocol therapy or any previous use of bisphosphonates.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No major surgery within 4 weeks of registration to protocol therapy.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "No adjuvant chemotherapy within 6 months of registration to protocol therapy.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No previous chemotherapy for metastatic disease.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No hormonal therapy in the adjuvant setting within 12 months of registration to protocol therapy; previous hormonal therapy must not have exceeded 6 months.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "No prior history of malignancy in the past 5 years with the exception of basal cell and squamous cell carcinoma of the skin.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has a history of lower urinary tract symptoms, including frequency, urgency, weak stream, incomplete emptying and intermittent flow for the past 9 months. He is otherwise healthy.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT00216060",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}